Seguir
Mikael Elofsson
Mikael Elofsson
Professor and Dean, Department of Chemistry, Faculty of Science and Technology, Umeå University
Dirección de correo verificada de umu.se
Título
Citado por
Citado por
Año
Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity
L Meng, R Mohan, BHB Kwok, M Elofsson, N Sin, CM Crews
Proceedings of the National Academy of Sciences 96 (18), 10403-10408, 1999
12151999
The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IκB kinase
BHB Kwok, B Koh, MKI Ndubuisi, M Elofsson, CM Crews
Chemistry & biology 8 (8), 759-766, 2001
6702001
Targeting bacterial virulence: inhibitors of type III secretion in Yersinia
AM Kauppi, R Nordfelth, H Uvell, H Wolf-Watz, M Elofsson
Chemistry & biology 10 (3), 241-249, 2003
2842003
Total synthesis of the-potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology
N Sin, KB Kim, M Elofsson, L Meng, H Auth, BHB Kwok, CM Crews
Bioorganic & medicinal chemistry letters 9 (15), 2283-2288, 1999
2721999
Small-molecule inhibitors specifically targeting type III secretion
R Nordfelth, AM Kauppi, HA Norberg, H Wolf-Watz, M Elofsson
Infection and immunity 73 (5), 3104-3114, 2005
2612005
A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis
S Muschiol, L Bailey, Å Gylfe, C Sundin, K Hultenby, S Bergström, ...
Proceedings of the National Academy of Sciences 103 (39), 14566-14571, 2006
2532006
Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram‐negative bacteria
P Keyser, M Elofsson, S Rosell, H Wolf‐Watz
Journal of internal medicine 264 (1), 17-29, 2008
2012008
Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide α', β'-epoxyketones
M Elofsson, U Splittgerber, J Myung, R Mohan, CM Crews
Chemistry & Biology 6 (11), 811-822, 1999
2011999
Inhibition of Type III Secretion in Salmonella enterica Serovar Typhimurium by Small-Molecule Inhibitors
DL Hudson, AN Layton, TR Field, AJ Bowen, H Wolf-Watz, M Elofsson, ...
Antimicrobial agents and chemotherapy 51 (7), 2631-2635, 2007
1622007
Derivatization procedures for reducing oligosaccharides, part 3: preparation of oligosaccharide glycosylamines, and their conversion into glycosaccharide-acrylamide copolymers
E Kallin, H Lönn, T Norberg, M Elofsson
Journal of Carbohydrate Chemistry 8 (4), 597-611, 1989
1471989
Salicylidene Acylhydrazides That Affect Type III Protein Secretion in Salmonella enterica Serovar Typhimurium
A Negrea, E Bjur, SE Ygberg, M Elofsson, H Wolf-Watz, M Rhen
Antimicrobial agents and chemotherapy 51 (8), 2867-2876, 2007
1392007
Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle
L Bailey, Å Gylfe, C Sundin, S Muschiol, M Elofsson, P Nordström, ...
FEBS letters 581 (4), 587-595, 2007
1322007
Preparation of building blocks for glycopeptide synthesis by glycosylation of Fmoc amino acids having unprotected carboxyl groups
LA Salvador, M Elofsson, J Kihlberg
Tetrahedron 51 (19), 5643-5656, 1995
1291995
Glycopeptides bind MHC molecules and elicit specific T cell responses.
CV Harding, J Kihlberg, M Elofsson, G Magnusson, ER Unanue
Journal of immunology (Baltimore, Md.: 1950) 151 (5), 2419-2425, 1993
1281993
Building blocks for glycopeptide synthesis: glycosylation of 3-mercaptopropionic acid and Fmoc amino acids with unprotected carboxyl groups
M Elofsson, B Walse, J Kihlberg
Tetrahedron letters 32 (51), 7613-7616, 1991
1221991
Removal of Acyl Protective Groups from Glycopeptides: Base Does Not Epimerize Peptide Stereocenters, and β-Elimination Is Slow
P Sjölin, M Elofsson, J Kihlberg
The Journal of organic chemistry 61 (2), 560-565, 1996
1111996
Identification of bacterial target proteins for the salicylidene acylhydrazide class of virulence-blocking compounds
D Wang, CE Zetterström, M Gabrielsen, KSH Beckham, JJ Tree, ...
Journal of Biological Chemistry 286 (34), 29922-29931, 2011
1082011
Reversal of the antichlamydial activity of putative type III secretion inhibitors by iron
A Slepenkin, PA Enquist, U Hägglund, LM de la Maza, M Elofsson, ...
Infection and immunity 75 (7), 3478-3489, 2007
962007
Preparation of Tn and sialyl Tn building blocks used in Fmoc solid-phase synthesis of glycopeptide fragments from HIV gp120
M Elofsson, LA Salvador, J Kihlberg
Tetrahedron 53 (1), 369-390, 1997
961997
Design, Synthesis, and Multivariate Quantitative Structure−Activity Relationship of SalicylanilidesPotent Inhibitors of Type III Secretion in Yersinia
MK Dahlgren, AM Kauppi, IM Olsson, A Linusson, M Elofsson
Journal of medicinal chemistry 50 (24), 6177-6188, 2007
902007
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20